EUVIMEDEUVIMED entdecken
Crossref

Urinary dipeptidase 1 and trefoil factor 1 are promising biomarkers for early diagnosis of colorectal cancer

Yusuke Okuda, Takaya Shimura iD, Yuichi Abe, Hiroyasu Iwasaki, Ruriko Nishigaki, Shigeki Fukusada, Naomi Sugimura, Mika Kitagawa, Tamaki Yamada, Ayumu Taguchi, Hiromi Kataoka

Journal of Gastroenterology · 2024

DOI: 10.1007/s00535-024-02110-1 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Gastroenterology, 2024. Verfasst von Yusuke Okuda und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gastroenterology and Metabolism, Nagoya City University Graduate School of Medical Sciences, 1-Kawasumi, Mizuho-Cho, Mizuho-Ku, Nagoya,…. Hauptthemen laut MEDLINE: Colorectal Neoplasms, Biomarkers, Tumor, Early Detection of Cancer, Trefoil Factor-1. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 39 Literaturangaben. Gefördert von: Japan Agency for Medical Research and Development (AMED), Nagoya City University, Hori Sciences and Arts Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Currently utilized serum tumor markers and fecal immunochemical tests do not have sufficient diagnostic power for colorectal cancer (CRC) due to their low sensitivities. To establish non-invasive urinary protein biomarkers for early CRC diagnosis, we performed stepwise analyses employing urine samples from CRCs and healthy controls (HCs). METHODS: Among 474 urine samples, 363 age- and sex-matched participants (188 HCs, 175 stage 0-III CRCs) were randomly divided into discovery (16 HCs, 16 CRCs), training (110 HCs, 110 CRCs), and validation (62 HCs, 49 CRCs) cohorts. RESULTS: Of the 23 urinary protein candidates comprehensively identified from mass spectrometry in the discovery cohort, urinary levels of dipeptidase 1 (uDPEP1) and Trefoil factor1 (uTFF1) were the two most significant diagnostic biomarkers for CRC in both training and validation cohorts using enzyme-linked immunosorbent assays. A urinary biomarker panel comprising uDPEP1 and uTFF1 significantly distinguished CRCs from HCs, showing area under the curves of 0.825-0.956 for stage 0-III CRC and 0.792-0.852 for stage 0/I CRC. uDPEP1 and uTFF1 also significantly distinguished colorectal adenoma (CRA) patients from HCs, with uDPEP1 and uTFF1 increasing significantly in the order of HCs, CRA patients, and CRC patients. Moreover, expression levels of DPEP1 and TFF1 were also significantly higher in the serum and tumor tissues of CRC, compared to HCs and normal tissues, respectively. CONCLUSIONS: This study established a promising and non-invasive urinary protein biomarker panel, which enables the early detection of CRC with high sensitivity.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Colorectal NeoplasmsBiomarkers, TumorEarly Detection of CancerTrefoil Factor-1DipeptidasesHumansMaleFemaleMiddle AgedAgedCase-Control StudiesNeoplasm StagingEnzyme-Linked Immunosorbent AssayAdultSensitivity and SpecificityAdenomaGPI-Linked Proteins

Stichwörter der Autor:innen

BiomarkerColorectal cancerDPEP1TFF1Urine

Substanzen

Biomarkers, TumorTrefoil Factor-1DipeptidasesTFF1 protein, humandipeptidase 1GPI-Linked Proteins

Autor:innen und Institutionen

  • Department of Gastroenterology and Metabolism, Nagoya City University Graduate School of Medical Sciences, 1-Kawasumi, Mizuho-Cho, Mizuho-Ku, Nagoya, 467-8601, Japan.
  • Department of Gastroenterology and Metabolism, Nagoya City University Graduate School of Medical Sciences, 1-Kawasumi, Mizuho-Cho, Mizuho-Ku, Nagoya, 467-8601, Japan. tshimura@med.nagoya-cu.ac.jp.
  • Division of Molecular Diagnostics, Aichi Cancer Center, 1-1 Kanokoden, Chikusa-Ku, Nagoya, Aichi, 464-8681, Japan.
  • Okazaki Public Health Center, 1-3 Harusaki, Harisaki-Cho, Okazaki, 444-0827, Japan.
  • Division of Advanced Cancer Diagnostics, Nagoya University Graduate School of Medicine, 65 Tsurumai-Cho, Showa-Ku, Nagoya, Aichi, 466-8550, Japan.

ORCID-Profile: Takaya Shimura

Förderung

  • Japan Agency for Medical Research and Development (AMED)
  • Nagoya City University
  • Hori Sciences and Arts Foundation

Zitieren

APA

Okuda, Y., Shimura, T., Abe, Y., Iwasaki, H., Nishigaki, R., Fukusada, S., Sugimura, N., Kitagawa, M., Yamada, T., Taguchi, A., & Kataoka, H. (2024). Urinary dipeptidase 1 and trefoil factor 1 are promising biomarkers for early diagnosis of colorectal cancer. Journal of Gastroenterology. https://doi.org/10.1007/s00535-024-02110-1

Vancouver

Okuda Y, Shimura T, Abe Y, Iwasaki H, Nishigaki R, Fukusada S, et al. Urinary dipeptidase 1 and trefoil factor 1 are promising biomarkers for early diagnosis of colorectal cancer. Journal of Gastroenterology. 2024. doi:10.1007/s00535-024-02110-1

BibTeX
@article{Okuda2024,
  author = {Okuda, Yusuke and Shimura, Takaya and Abe, Yuichi and Iwasaki, Hiroyasu and Nishigaki, Ruriko and Fukusada, Shigeki and Sugimura, Naomi and Kitagawa, Mika and Yamada, Tamaki and Taguchi, Ayumu and Kataoka, Hiromi},
  title = {Urinary dipeptidase 1 and trefoil factor 1 are promising biomarkers for early diagnosis of colorectal cancer},
  journal = {Journal of Gastroenterology},
  year = {2024},
  doi = {10.1007/s00535-024-02110-1}
}
Kostenlos starten →